BridgeMD
New treatment option for Diabetes
Official title Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events
ClinicalTrials.gov ID: NCT06893341
What this study is testing
- What it's testing
- The purpose of this study is to determine whether an array of biosensors can noninvasively identify hyperglycemic or hypoglycemic events in persons diagnosed with diabetes through noninvasive detection of volatile organic compounds in exhaled breath.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 19
You may be able to join if
- Who are diagnosed with type 1 diabetes.
- Who are between 12-19 years of age.
- That utilize a Dexcom (G6 or G7) continuous glucose monitoring device.
- That have an established working CGM for at least 12 hours (that does not need to be replaced within 24 hours).
- That are willing to share their daily CGM data for the study.
You likely can't join if
- That are smokers or use tobacco products or who live with someone who smokes in their vicinity.
- That have a condition or abnormality other than type 1 diabetes that in the opinion of the Investigator would compromise the safety of the subject or...
- That utilize closed-loop diabetes management systems.
- That have symptoms or recently been diagnosed with an upper respiratory illness including COVID-19.
- That themselves or a close family member (living within the same household at the time of the data collection period) is on a "ketogenic diet".
- That themselves or a close family member is working in an industry with high and continuous exposure to exogenous VOCs. Examples of such industries...
See the full eligibility criteria
- Who are diagnosed with type 1 diabetes.
- Who are between 12-19 years of age.
- That utilize a Dexcom (G6 or G7) continuous glucose monitoring device.
- That have an established working CGM for at least 12 hours (that does not need to be replaced within 24 hours).
- That are willing to share their daily CGM data for the study.
- That are the only individuals in their household with any type of diabetes diagnosis (type 1 or type 2).
- That are willing to return the device within 24-48 hours of study completion.
- That are located in Indianapolis, IN or its suburban areas.
- That are smokers or use tobacco products or who live with someone who smokes in their vicinity.
- That have a condition or abnormality other than type 1 diabetes that in the opinion of the Investigator would compromise the safety of the subject or the quality of the data.
- That utilize closed-loop diabetes management systems.
- That have symptoms or recently been diagnosed with an upper respiratory illness including COVID-19.
- That themselves or a close family member (living within the same household at the time of the data collection period) is on a "ketogenic diet".
- That themselves or a close family member is working in an industry with high and continuous exposure to exogenous VOCs. Examples of such industries include beauty salons and paint manufacturers.
- That are unable or unwilling to cooperate with sample collection.
The study team makes the final eligibility decision.
Where it's taking place
- Indianapolis, Indiana, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 19 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Indianapolis, Indiana, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.